Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 11/20 | 0.43 |
| ▸ | MMP13 | P45452 | 9/20 | 0.43 |
| ▸ | MMP9 | P14780 | 8/20 | 0.43 |
| ▸ | MMP8 | P22894 | 6/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | BMP1 | P13497 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7422384 | 1.00 | MMP2 (0.43) | MMP2MMP13MMP9MMP8POLB | |
| Hydrochloric Acid SCHEMBL7420713 | 0.99 | MMP2 (0.43) | MMP2MMP13MMP9MMP8POLB | |
| Hydrochloric Acid SCHEMBL7420711 | 0.99 | MMP2 (0.43) | MMP2MMP13MMP9MMP8POLB | |
| SCHEMBL6056805 | 0.93 | POLB (0.46) | MMP2MMP13MMP9MMP8POLB | |
| SCHEMBL6056808 | 0.93 | POLB (0.46) | MMP2MMP13MMP9MMP8POLB | |
| Hydrochloric Acid SCHEMBL7422833 | 0.93 | POLB (0.45) | MMP2MMP13MMP9MMP8POLB | |
| Hydrochloric Acid SCHEMBL7422839 | 0.93 | POLB (0.45) | MMP2MMP13MMP9MMP8POLB | |
| Hydrochloric Acid SCHEMBL7418803 | 0.92 | BMP1 (0.49) | MMP2MMP13MMP9MMP8BMP1 | |
| Hydrochloric Acid SCHEMBL7418805 | 0.92 | BMP1 (0.49) | MMP2MMP13MMP9MMP8BMP1 | |
| SCHEMBL6907245 | 0.92 | MMP2 (0.44) | MMP2MMP13MMP9MMP8POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0873312-B1 | ALPHA-SUBSTITUTED ARYLSULPHONAMIDO HYDROXAMIC ACIDS AS TNF-ALPHA AND MATRIX METALLOPROTEINASE INHIBITORS | NOVARTIS AG (CH) | 2002-06-12 | — | — | EP | claimed |
| EP-0873312-A1 | ALPHA-SUBSTITUTED ARYLSULPHONAMIDO HYDROXAMIC ACIDS AS TNF-ALPHA AND MATRIX METALLOPROTEINASE INHIBITORS | Novartis AG (CH) | 1998-10-28 | — | — | EP | claimed |
| WO-1997022587-A1 | ALPHA-SUBSTITUTED ARYLSULPHONAMIDO HYDROXAMIC ACIDS AS TNF-ALPHA AND MATRIX METALLOPROTEINASE INHIBITORS | NOVARTIS AG (CH) | 1997-06-26 | — | — | WO | claimed |